GlassScriptPhysician profile
Amanda Mirmanesh
NPI 1871158030
$2,131.62
in general payments reported to CMS, 2019-2025
13 companies · $434 in 2025
The $434 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $11.77 · 2023: $1,285 · 2024: $401 · 2025: $434.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,256 · Food and Beverage: $864.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,255.94 |
| Food and Beverage | $863.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $1,260.05 | 2023-2024 | Da Vinci Surgical System |
| Revance Therapeutics, INC. | $168.28 | 2025 | Daxxify |
| Galderma Laboratories, L.P. | $136.96 | 2024 | |
| Abbvie INC. | $127.06 | 2025 | |
| Astellas Pharma US INC | $106.80 | 2024-2025 | Veozah |
| Sumitomo Pharma America, INC. | $92.42 | 2024-2025 | Myfembree |
| Sage Therapeutics, LLC | $86.21 | 2024-2025 | Zurzuvae |
| Bayer Healthcare Pharmaceuticals INC. | $42.85 | 2024 | |
| Exact Sciences Corporation | $30.02 | 2025 | Cologuard Collection Kit |
| Organon LLC | $25.10 | 2022-2023 | Nexplanon |
| Davol INC. | $20.34 | 2024 | Arista Ah Flexitip |
| Medtronic, INC. | $19.60 | 2024 | Truclear |
| Exeltis, USA INC. | $15.93 | 2023 | Slynd |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Mirmanesh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.